Skip to main content

Table 1 Patient characteristics

From: Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses

  Group with bilateral hip prostheses Control group
Sample size 17 50
Median age (years), range 77, 65–84 77, 64–83
T stage: ≤ T1c 2 (12%) 3 (6%)
T2a–T2c 7 (41%) 43 (86%)
 ≥ T3a 8 (47%) 4 (8%)
Androgen deprivation therapy
 None 2 (12%) 6 (12%)
 < 6 months 1 (6%) 1 (2%)
 6–12 months 4 (24%) 43 (86%)
 > 12 months 10 (59%) 0 (0%)
Radiotherapy prescription
 57 Gy in 19 fractions 3 (18%) 8 (16%)
 60 Gy in 20 fractions 14 (82%) 42 (84%)
Median CTV volume (cc), range 56.3, 21.8–144.1 47.1, 22.1–135.9
Bladder filling: empty 14 (82%) 39 (78%)
full 3 (18%) 11 (22%)
Median hip separation (cm), range 13.5 (11.2, 16.2) 12.8 (10.8,14.5)